Anti-cancer
Bendamustine HCl
Also known as: Bendamustine Hydrochloride
CAS No.
3543-75-7
A bifunctional alkylating agent used in injectable oncology formulations for chronic lymphocytic leukemia and non-Hodgkin lymphoma.
Bendamustine HCl is an alkylating agent oncology API manufactured by NovaAcura Biotech under GMP-compliant conditions appropriate to cytotoxic API handling. The company supplies full batch documentation and regulatory support to global oncology formulation partners.
Applications & Uses
A bifunctional alkylating agent used in injectable oncology formulations for chronic lymphocytic leukemia and non-Hodgkin lymphoma.
Full technical documentation, batch specifications and regulatory support (DMF/CEP) are available on request.
Need This Molecule at Scale?
Get in touch for pricing, lead times and full regulatory documentation.
Get In Touch